FDA Approved: ENSACOVE — Original Application (Xcovery Holdings, Inc.)

View source ↗

Summary

FDA approved ENSARTINIB (ENSACOVE) from Xcovery Holdings in an original application for adults with ALK-positive metastatic non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ENSACOVE (ensartinib)

Snippet

ORIG AP for ENSACOVE (ENSARTINIB)